Cargando…
The impact of the COVID-19 pandemic on cancer care
The COVID-19 pandemic has disrupted the spectrum of cancer care, including delaying diagnoses and treatment and halting clinical trials. In response, healthcare systems are rapidly reorganizing cancer services to ensure that patients continue to receive essential care while minimizing exposure to SA...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group US
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7238956/ https://www.ncbi.nlm.nih.gov/pubmed/35121972 http://dx.doi.org/10.1038/s43018-020-0074-y |
_version_ | 1783536621195362304 |
---|---|
author | Richards, Mike Anderson, Michael Carter, Paul Ebert, Benjamin L. Mossialos, Elias |
author_facet | Richards, Mike Anderson, Michael Carter, Paul Ebert, Benjamin L. Mossialos, Elias |
author_sort | Richards, Mike |
collection | PubMed |
description | The COVID-19 pandemic has disrupted the spectrum of cancer care, including delaying diagnoses and treatment and halting clinical trials. In response, healthcare systems are rapidly reorganizing cancer services to ensure that patients continue to receive essential care while minimizing exposure to SARS-CoV-2 infection. |
format | Online Article Text |
id | pubmed-7238956 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Nature Publishing Group US |
record_format | MEDLINE/PubMed |
spelling | pubmed-72389562020-05-20 The impact of the COVID-19 pandemic on cancer care Richards, Mike Anderson, Michael Carter, Paul Ebert, Benjamin L. Mossialos, Elias Nat Cancer Comment The COVID-19 pandemic has disrupted the spectrum of cancer care, including delaying diagnoses and treatment and halting clinical trials. In response, healthcare systems are rapidly reorganizing cancer services to ensure that patients continue to receive essential care while minimizing exposure to SARS-CoV-2 infection. Nature Publishing Group US 2020-05-20 2020 /pmc/articles/PMC7238956/ /pubmed/35121972 http://dx.doi.org/10.1038/s43018-020-0074-y Text en © Springer Nature America, Inc. 2020 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Comment Richards, Mike Anderson, Michael Carter, Paul Ebert, Benjamin L. Mossialos, Elias The impact of the COVID-19 pandemic on cancer care |
title | The impact of the COVID-19 pandemic on cancer care |
title_full | The impact of the COVID-19 pandemic on cancer care |
title_fullStr | The impact of the COVID-19 pandemic on cancer care |
title_full_unstemmed | The impact of the COVID-19 pandemic on cancer care |
title_short | The impact of the COVID-19 pandemic on cancer care |
title_sort | impact of the covid-19 pandemic on cancer care |
topic | Comment |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7238956/ https://www.ncbi.nlm.nih.gov/pubmed/35121972 http://dx.doi.org/10.1038/s43018-020-0074-y |
work_keys_str_mv | AT richardsmike theimpactofthecovid19pandemiconcancercare AT andersonmichael theimpactofthecovid19pandemiconcancercare AT carterpaul theimpactofthecovid19pandemiconcancercare AT ebertbenjaminl theimpactofthecovid19pandemiconcancercare AT mossialoselias theimpactofthecovid19pandemiconcancercare AT richardsmike impactofthecovid19pandemiconcancercare AT andersonmichael impactofthecovid19pandemiconcancercare AT carterpaul impactofthecovid19pandemiconcancercare AT ebertbenjaminl impactofthecovid19pandemiconcancercare AT mossialoselias impactofthecovid19pandemiconcancercare |